| ANOVA | Analysis of variance |
| AVE | Aortic valve endocarditis |
| AVR | Aortic valve replacement |
| CABG | Coronary artery bypass graft |
| COPD | Chronic obstructive pulmonary disease |
| CRP | C-reactive protein |
| ECC | Extracorporal circulation |
| ECLS | Extracorporeal life support |
| ENT | Ear, nose, throat |
| GFR | Glomerular filtration rate |
| HF | Heart Failure |
| HRQOL | Health-related quality of life |
| ICU | Intensive care unit |
| IE | Infective endocarditis |
| LV | Left ventricle |
| LVEF | Left ventricular ejection fraction |
| MLHFQ | Minnesota Living with HF Questionnaire |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| NT-proBNP | N-terminal prohormone of brain natriuretic peptide |
| NVE | Native valve endocarditis |
| NYHA | New York Heart Association |
| OR | Odds ratio |
| PAOD | Peripheral arterial occlusive disease |
| PCT | Procalcitonin |
| PVE | Prosthetic valve endocarditis |
| QOL | Quality of life |
| RIFLE | Risk, injury, failure, loss of kidney function and end-stage kidney disease |
| TEE | Transesophageal echocardiography |
| VSD | Ventricular septum defect |
| WBC | White blood cell count |